Answers are grounded in this paper and cite their sources.
Here we report a novel method for detecting 3,4-dihydroxyphenylalanine (L-DOPA) and tyrosinase (TR) activity based on surface-enhance Raman scattering (SERS) by employing a large-scale versatile three-dimensionally (3D) ordered nanocomposite (SiO2/GNPs) array as a nanosensor. L-DOPA could reduce AuCl4− to Au0 and enlarge the gold nanoparticles (GNPs) that attach on the surface of the SiO2/GNPs array, the preadsorbed GNPs serve as nucleation sites for Au0 to deposit. As the concentration of L-DOPA increases, the surface coverage of resultant Au0 on silica cores increases accordingly until complete gold nanoshells (GNSs) are formed. During the growth procedure, the SERS-activity of the GNSs arrays correlate well with the concentration of L-DOPA, which indicates that this SiO2/GNPs array is a potential nanosensor for detecting L-DOPA. As TR can catalyze the hydroxylation of L-tyrosine to form L-DOPA, this approach can also be employed to analyze the activity of TR, which possesses vast clinical and food industrial importance. Compounds such as cinnamic acid and p-hydroxybenzoic acid can inhibit the TR activity. Thus, the TR-triggered growth of the GNSs array system can also be used to detect the TR inhibited activity of inhibitors.
No takes yet. Share an insight, caveat, or question.
Rao et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: